Ratings
0
Nobody has rated this yet. Be the first!
Works
5
FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation
Characterizing genetic variants for clinical action
Actionable exomic incidental findings in 6503 participants: challenges of variant classification
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Exploring concordance and discordance for return of incidental findings from clinical sequencing
